See more : Pollard Banknote Limited (PBL.TO) Income Statement Analysis – Financial Results
Complete financial analysis of IntriCon Corporation (IIN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of IntriCon Corporation, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- WAM Active Limited (WAA.AX) Income Statement Analysis – Financial Results
- Evogene Ltd. (EVGN) Income Statement Analysis – Financial Results
- SKAGEN – Vekst (SKIVEK.CO) Income Statement Analysis – Financial Results
- Infotel SA (0OQQ.L) Income Statement Analysis – Financial Results
- Gestion De Inmuebles Logis Confort Sa (MLLOG.PA) Income Statement Analysis – Financial Results
IntriCon Corporation (IIN)
About IntriCon Corporation
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. It offers micro-miniature products, microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components, and assemblies and software solutions for medical devices, hearing healthcare, and professional audio communication devices markets. The company also provides micro coils for surgical navigation clinical applications, such as interventional pulmonology and electrophysiology; joint engineering and manufacturing services for complex medical devices, including catheters covering a range of applications for cardiology, peripheral vascular, neurology, radiology, and pulmonology; bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system; and safety needle products for original equipment manufacturing customers. In addition, it offers professional audio headset products used for emergency response needs in the fire, law enforcement, safety, aviation, and military markets; and a line of miniature ear- and head-worn devices used by performers and support staff in the music and stage performance markets. The company sells its hearing device products, and medical and professional audio communications products directly to hearing instrument manufacturers, distributors, and partnerships; and microphone products to the radio communication and professional audio industries, as well as markets and sells hearing aid devices directly to consumers through direct mail advertising, Internet, and call center. The company was formerly known as Selas Corporation of America and changed its name to IntriCon Corporation. The company was incorporated in 1930 and is headquartered in Arden Hills, Minnesota.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 125.21M | 102.77M | 113.49M | 116.46M | 88.31M | 68.01M | 69.74M | 68.30M | 52.96M | 63.93M | 56.06M | 58.70M | 51.68M | 65.56M | 68.98M | 51.73M | 44.46M | 35.18M | 36.20M | 64.59M | 86.31M | 116.29M | 102.80M | 99.60M | 111.20M | 103.40M | 71.20M | 73.70M | 52.30M | 27.60M | 40.30M | 54.60M | 51.40M | 41.00M | 38.80M | 28.60M | 29.20M |
| Cost of Revenue | 93.82M | 76.60M | 82.51M | 79.30M | 61.82M | 50.94M | 50.74M | 49.82M | 40.79M | 48.96M | 43.39M | 43.68M | 40.62M | 49.51M | 51.74M | 39.30M | 32.85M | 27.31M | 27.99M | 52.45M | 66.97M | 88.70M | 77.30M | 73.00M | 84.20M | 78.10M | 49.30M | 50.10M | 38.70M | 20.00M | 27.80M | 40.10M | 39.00M | 31.30M | 27.40M | 20.70M | 24.90M |
| Gross Profit | 31.39M | 26.18M | 30.99M | 37.16M | 26.49M | 17.07M | 19.00M | 18.48M | 12.17M | 14.98M | 12.67M | 15.01M | 11.05M | 16.05M | 17.24M | 12.42M | 11.60M | 7.87M | 8.22M | 12.14M | 19.34M | 27.58M | 25.50M | 26.60M | 27.00M | 25.30M | 21.90M | 23.60M | 13.60M | 7.60M | 12.50M | 14.50M | 12.40M | 9.70M | 11.40M | 7.90M | 4.30M |
| Gross Profit Ratio | 25.07% | 25.47% | 27.30% | 31.91% | 30.00% | 25.10% | 27.25% | 27.06% | 22.98% | 23.42% | 22.59% | 25.58% | 21.39% | 24.48% | 25.00% | 24.01% | 26.10% | 22.37% | 22.70% | 18.80% | 22.40% | 23.72% | 24.81% | 26.71% | 24.28% | 24.47% | 30.76% | 32.02% | 26.00% | 27.54% | 31.02% | 26.56% | 24.12% | 23.66% | 29.38% | 27.62% | 14.73% |
| Research & Development | 5.32M | 5.25M | 3.83M | 4.67M | 4.46M | 4.69M | 5.21M | 4.83M | 4.18M | 4.69M | 4.88M | 4.49M | 3.34M | 3.25M | 3.09M | 2.12M | 1.82M | 1.49M | 1.76M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 16.58M | 15.01M | 13.93M | 13.01M | 10.34M | 9.15M | 7.10M | 6.46M | 5.79M | 5.96M | 5.80M | 5.80M | 5.37M | 6.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 17.14M | 18.05M | 17.40M | 17.90M | 16.30M | 15.00M | 14.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 8.28M | 6.67M | 11.50M | 12.37M | 9.45M | 4.70M | 3.92M | 3.70M | 3.31M | 3.32M | 3.19M | 3.13M | 2.96M | 3.96M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 24.85M | 21.68M | 25.43M | 25.38M | 19.79M | 13.85M | 11.02M | 10.16M | 9.10M | 9.28M | 8.98M | 8.93M | 8.34M | 10.75M | 10.89M | 8.33M | 8.36M | 9.42M | 8.87M | 16.83M | 17.14M | 18.05M | 17.40M | 17.90M | 16.30M | 15.00M | 14.40M | 14.70M | 9.70M | 8.60M | 8.50M | 8.10M | 6.70M | 7.40M | 6.80M | 6.90M | 4.90M |
| Other Expenses | 729.00K | 1.15M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2.62M | 378.86K | 3.00 | 0.00 | 3.98M | 4.00M | 3.80M | 3.50M | 2.80M | 2.80M | 2.70M | 1.30M | 900.00K | 700.00K | 700.00K | 600.00K | 600.00K | 600.00K | 400.00K | 300.00K |
| Operating Expenses | 30.90M | 28.08M | 29.26M | 30.05M | 24.24M | 18.54M | 16.24M | 14.99M | 13.28M | 13.98M | 13.86M | 13.42M | 11.68M | 14.00M | 13.98M | 10.45M | 10.18M | 8.28M | 11.01M | 16.83M | 17.14M | 22.03M | 21.40M | 21.70M | 19.80M | 17.80M | 17.20M | 17.40M | 11.00M | 9.50M | 9.20M | 8.80M | 7.30M | 8.00M | 7.40M | 7.30M | 5.20M |
| Cost & Expenses | 124.72M | 104.68M | 111.77M | 109.35M | 86.06M | 69.48M | 66.97M | 64.81M | 54.07M | 62.93M | 57.25M | 57.10M | 52.31M | 63.51M | 65.72M | 49.76M | 43.03M | 35.59M | 39.00M | 69.28M | 84.12M | 110.73M | 98.70M | 94.70M | 104.00M | 95.90M | 66.50M | 67.50M | 49.70M | 29.50M | 37.00M | 48.90M | 46.30M | 39.30M | 34.80M | 28.00M | 30.10M |
| Interest Income | 0.00 | 331.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 19.89K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 21.00K | 0.00 | 0.00 | 314.00K | 716.00K | 553.00K | 369.00K | 461.00K | 600.00K | 755.00K | 609.00K | 655.00K | 836.59K | 702.22K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 5.54M | 4.62M | 3.28M | 2.94M | 2.19M | 2.04M | 1.76M | 2.18M | 2.45M | 2.15M | 2.26M | 2.60M | 2.47M | 2.43M | 2.13M | 1.85M | 2.07M | 2.46M | 2.71M | 2.95M | 4.03M | 3.98M | 4.00M | 3.80M | 3.50M | 2.80M | 2.80M | 2.70M | 1.30M | 900.00K | 700.00K | 700.00K | 600.00K | 600.00K | 600.00K | 400.00K | 300.00K |
| EBITDA | 5.59M | 2.16M | -299.00K | 9.29M | 4.72M | -1.78M | 4.37M | 5.32M | -2.90M | 3.78M | 1.28M | 3.76M | -647.59K | 4.43M | 4.18M | 3.19M | 4.01M | 3.69M | -1.76M | -19.36M | 381.84K | 8.75M | 6.70M | 7.70M | 9.90M | 9.30M | 6.50M | 7.70M | 3.60M | -4.50M | 6.70M | 7.50M | 5.60M | 2.00M | 1.90M | 600.00K | -400.00K |
| EBITDA Ratio | 4.47% | 2.10% | -0.26% | 7.98% | 5.34% | -2.61% | 6.27% | 7.79% | -5.47% | 5.91% | 2.29% | 6.41% | -1.25% | 6.76% | 6.05% | 6.16% | 9.01% | 10.50% | -4.85% | -29.98% | 0.44% | 7.52% | 6.52% | 7.73% | 8.90% | 8.99% | 9.13% | 10.45% | 6.88% | -16.30% | 16.63% | 13.74% | 10.89% | 4.88% | 4.90% | 2.10% | -1.37% |
| Operating Income | 50.00K | -3.08M | -2.04M | 7.11M | 2.25M | -1.60M | 2.77M | 3.41M | -1.34M | 1.00M | -1.19M | 1.59M | -629.73K | 2.04M | 3.26M | 1.97M | 1.42M | -412.22K | -2.80M | -4.69M | 2.19M | 5.55M | 4.10M | 4.90M | 7.20M | 7.50M | 4.70M | 6.20M | 2.60M | -1.90M | 3.30M | 5.70M | 5.10M | 1.70M | 4.00M | 600.00K | -900.00K |
| Operating Income Ratio | 0.04% | -2.99% | -1.80% | 6.11% | 2.54% | -2.36% | 3.97% | 4.99% | -2.53% | 1.56% | -2.13% | 2.72% | -1.22% | 3.12% | 4.73% | 3.80% | 3.20% | -1.17% | -7.72% | -7.26% | 2.54% | 4.78% | 3.99% | 4.92% | 6.47% | 7.25% | 6.60% | 8.41% | 4.97% | -6.88% | 8.19% | 10.44% | 9.92% | 4.15% | 10.31% | 2.10% | -3.08% |
| Total Other Income/Expenses | 21.00K | 647.00K | 177.00K | -1.08M | -1.08M | -1.16M | -630.00K | -462.00K | -735.00K | -127.00K | -393.00K | -794.00K | -1.21M | -741.97K | -1.22M | -552.35K | -250.37K | -402.03K | -654.72K | -233.83K | -561.82K | -790.49K | -1.40M | -1.00M | -800.00K | -1.00M | -1.00M | -1.20M | -300.00K | 100.00K | 2.70M | 1.10M | -100.00K | -300.00K | -2.70M | -400.00K | 200.00K |
| Income Before Tax | 71.00K | -2.43M | -1.86M | 6.03M | 1.16M | -2.76M | 2.14M | 2.95M | -2.07M | 873.00K | -1.59M | 800.00K | -1.84M | 1.30M | 2.05M | 1.41M | 1.17M | -814.25K | -3.45M | -4.92M | 1.63M | 4.76M | 2.70M | 3.90M | 6.40M | 6.50M | 3.70M | 5.00M | 2.30M | -1.80M | 6.00M | 6.80M | 5.00M | 1.40M | 1.30M | 200.00K | -700.00K |
| Income Before Tax Ratio | 0.06% | -2.36% | -1.64% | 5.18% | 1.32% | -4.05% | 3.06% | 4.31% | -3.91% | 1.37% | -2.83% | 1.36% | -3.55% | 1.99% | 2.97% | 2.74% | 2.63% | -2.31% | -9.53% | -7.62% | 1.89% | 4.10% | 2.63% | 3.92% | 5.76% | 6.29% | 5.20% | 6.78% | 4.40% | -6.52% | 14.89% | 12.45% | 9.73% | 3.41% | 3.35% | 0.70% | -2.40% |
| Income Tax Expense | 135.00K | 61.00K | 201.00K | 484.00K | 8.00K | 217.00K | 19.00K | 428.00K | 217.00K | 164.00K | -160.00K | 145.00K | -33.82K | 264.07K | 180.67K | 174.46K | 409.42K | 1.14M | 510.99K | -753.04K | 973.76K | 1.83M | 1.00M | 300.00K | 2.00M | 2.40M | 1.40M | 1.90M | 1.00M | -400.00K | 1.60M | 2.50M | 2.10M | 1.00M | 600.00K | 300.00K | 200.00K |
| Net Income | -64.00K | -2.52M | -3.78M | 5.55M | 1.80M | -4.59M | 2.23M | 2.25M | -6.16M | 709.00K | -1.43M | 361.00K | -3.92M | 1.04M | 1.87M | 1.16M | 1.53M | 94.87K | -4.97M | -21.55M | -4.62M | 2.94M | 1.70M | 3.60M | 4.40M | 4.10M | 2.30M | 3.10M | 1.30M | -5.00M | 4.40M | 4.30M | 2.90M | 400.00K | 700.00K | -100.00K | -700.00K |
| Net Income Ratio | -0.05% | -2.46% | -3.33% | 4.76% | 2.04% | -6.74% | 3.19% | 3.29% | -11.63% | 1.11% | -2.54% | 0.62% | -7.59% | 1.58% | 2.71% | 2.25% | 3.44% | 0.27% | -13.74% | -33.37% | -5.35% | 2.52% | 1.65% | 3.61% | 3.96% | 3.97% | 3.23% | 4.21% | 2.49% | -18.12% | 10.92% | 7.88% | 5.64% | 0.98% | 1.80% | -0.35% | -2.40% |
| EPS | -0.01 | -0.28 | -0.43 | 0.64 | 0.26 | -0.71 | 0.38 | 0.39 | -1.08 | 0.13 | -0.25 | 0.07 | -0.73 | 0.20 | 0.36 | 0.23 | 0.30 | 0.02 | -0.97 | -4.21 | -0.90 | 0.57 | 0.33 | 0.69 | 0.84 | 0.78 | 0.44 | 0.60 | 0.19 | -0.69 | 0.63 | 0.73 | 0.29 | 0.04 | 0.07 | -0.01 | -0.07 |
| EPS Diluted | -0.01 | -0.28 | -0.43 | 0.64 | 0.25 | -0.71 | 0.36 | 0.37 | -1.08 | 0.12 | -0.25 | 0.07 | -0.73 | 0.19 | 0.34 | 0.22 | 0.29 | 0.02 | -0.97 | -4.21 | -0.90 | 0.57 | 0.33 | 0.68 | 0.82 | 0.77 | 0.44 | 0.60 | 0.19 | -0.69 | 0.63 | 0.73 | 0.29 | 0.04 | 0.07 | -0.01 | -0.07 |
| Weighted Avg Shares Out | 9.08M | 8.89M | 8.75M | 8.63M | 6.85M | 6.50M | 5.91M | 5.79M | 5.70M | 5.67M | 5.60M | 5.48M | 5.39M | 5.31M | 5.19M | 5.05M | 5.10M | 4.74M | 5.13M | 5.12M | 5.13M | 5.15M | 5.15M | 5.22M | 5.24M | 5.26M | 5.19M | 5.19M | 6.67M | 7.21M | 7.02M | 5.86M | 10.00M | 10.00M | 10.00M | 10.00M | 9.55M |
| Weighted Avg Shares Out (Dil) | 9.08M | 8.89M | 8.75M | 8.63M | 7.31M | 6.50M | 6.24M | 6.04M | 5.70M | 5.89M | 5.60M | 5.54M | 5.39M | 5.54M | 5.49M | 5.28M | 5.27M | 4.74M | 5.13M | 5.12M | 5.13M | 5.15M | 5.15M | 5.29M | 5.37M | 5.30M | 5.19M | 5.19M | 6.67M | 7.21M | 7.02M | 5.86M | 10.00M | 10.00M | 10.00M | 10.00M | 9.55M |
Intricon Announces Completion of Acquisition by an Affiliate of Altaris Capital Partners
Investment by Altaris Supports Intricon's Ability to Deliver Innovative Solutions and Service to its Customers Investment by Altaris Supports Intricon's Ability to Deliver Innovative Solutions and Service to its Customers
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates OBNK, IIN, Y, VEC
NEW YORK , April 26, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Origin Bancorp,...
TTDKY vs. IIN: Which Stock Should Value Investors Buy Now?
TTDKY vs. IIN: Which Stock Is the Better Value Option?
INTRICON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intricon Corporation - IIN
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Intricon Corporation (NasdaqGM: IIN) to an affiliate of Altaris Capital Partners,...
INTRICON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intricon Corporation - IIN
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Intricon Corporation (NasdaqGM: IIN) to an affiliate of Altaris Capital Partners,...
Stocks To Invest In Right Now? 5 Health Care Stocks For Your March Watchlist
Do these healthcare stocks pique your interest?
IntriCon Corporation (IIN) Stock: Why It Surged Today
The IntriCon Corporation (NASDAQ: IIN) stock increased by 37.37% today. This is why.
SHAREHOLDER ALERT: WeissLaw LLP Investigates IntriCon Corporation
NEW YORK , Feb. 28, 2022 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of IntriCon Corporation ("IntriCon" or the "Company") (NASDAQ: IIN), in connection with the proposed acquisition...
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Intricon Corporation Buyout
Wilmington, Delaware--(Newsfile Corp. - February 28, 2022) - Rigrodsky Law, P.A. announces that it is investigating Intricon Corporation ("Intricon") (NASDAQ: IIN) regarding possible breaches of fiduciary duties and other violations of law related to Intricon's agreement to be acquired by...
Why Are Intricon Shares Surging Monday
Altaris Capital Partners LLC will acquire Implantable device maker Intricon Corporation (NASDAQ: IIN) for $24.25 per share in a transaction that values Intricon at an equity value of approximately $241 million. The purchase price represents a premium of approximately 39%.
Source: https://incomestatements.info
Category: Stock Reports